Zobrazeno 1 - 10
of 281
pro vyhledávání: '"Hsiang-Lin Tsai"'
Autor:
Yen-Cheng Chen, Ching-Wen Huang, Ching-Chun Li, Tsung-Kun Chang, Wei-Chih Su, Po-Jung Chen, Yung-Sung Yeh, Yu-Tang Chang, Hsiang-Lin Tsai, Ming-Chen Paul Shih, Jaw-Yuan Wang
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background Systemic therapy is the standard treatment for unresectable colorectal cancer with liver metastasis (CRCLM). Transarterial chemoembolization with drug-eluting beads (DEB-TACE) is considered an effective treatment option for CRCLM.
Externí odkaz:
https://doaj.org/article/8f8a694213d340359c249d54b9c10668
Autor:
Hsiang-Lin Tsai MD, PhD, Yung-Sung Yeh MD, Po-Jung Chen MD, Yu-Tang Chang MD, Yen-Cheng Chen MD, Wei-Chih Su MD, Tsung-Kun Chang MD, Ching-Wen Huang MD, PhD, Jaw-Yuan Wang MD, PhD
Publikováno v:
Integrative Cancer Therapies, Vol 22 (2023)
Patients with cancer use low-molecular-weight fucoidan (LMF) as a supplement to therapy. However, most studies of LMF are in vitro or conducted using animals. Concurrent chemoradiotherapy (CCRT) is the gold standard for locally advanced rectal cancer
Externí odkaz:
https://doaj.org/article/115072fd734a4b80970c03e100dfcbe5
Autor:
Hsiang-Lin Tsai, Ching-Wen Huang, Yen-Cheng Chen, Wei-Chih Su, Tsung-Kun Chang, Po-Jung Chen, Ching-Chun Li, Yu-Tang Chang, Jaw-Yuan Wang
Publikováno v:
Medicina, Vol 59, Iss 12, p 2108 (2023)
Background and Objectives: Approximately 5–10% of all patients with metastatic colorectal cancer (mCRC) harbor a BRAFV600E mutation. These patients exhibit distinct metastatic patterns, poor prognosis, and heterogenous survival outcomes. The findin
Externí odkaz:
https://doaj.org/article/fdab3b5083a14fe8a83a26180c2d9407
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 39, Iss 10, Pp 1054-1055 (2023)
Externí odkaz:
https://doaj.org/article/0f11ea971c49498ab77f25de9cb5b4f9
Autor:
Tzu-Chieh Yin, Po-Jung Chen, Yung-Sung Yeh, Ching-Chun Li, Yen-Cheng Chen, Wei-Chih Su, Tsung-Kun Chang, Ching-Wen Huang, Chun-Ming Huang, Hsiang-Lin Tsai, Jaw-Yuan Wang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundNeoadjuvant chemoradiotherapy followed by total mesorectal excision is the standard treatment for patients with nonmetastatic locally advanced rectal cancer (LARC). However, for patients with LARC and synchronous metastasis, the optimal tre
Externí odkaz:
https://doaj.org/article/5d7444be5dec42e79094795e633f37cd
Autor:
Wei-Chih Su, Yi-Chen Tsai, Hsiang-Lin Tsai, Tsung-Kun Chang, Tzu-Chieh Yin, Ching-Wen Huang, Yen-Cheng Chen, Ching-Chun Li, Po-Jung Chen, Yun-Ru Liu, Tsung-Han Hsieh, Jaw-Yuan Wang
Publikováno v:
Current Issues in Molecular Biology, Vol 44, Iss 4, Pp 1552-1563 (2022)
Personalized treatments based on the genetic profiles of tumors can simultaneously optimize efficacy and minimize toxicity, which is beneficial for improving patient outcomes. This study aimed to integrate gene alterations associated with predictive
Externí odkaz:
https://doaj.org/article/be391802ddaa4c7b806bb867d711857e
Autor:
Yuan-Chin Hsieh, Jun-min Liao, Kuo-Hsiang Chuang, Kai-Wen Ho, Shih-Ting Hong, Hui-Ju Liu, Bo-Cheng Huang, I-Ju Chen, Yen-Ling Liu, Jaw-Yuan Wang, Hsiang-Lin Tsai, Yu-Cheng Su, Yen-Tseng Wang, Tian-Lu Cheng
Publikováno v:
Journal of Nanobiotechnology, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background Humanization of mouse monoclonal antibodies (mAbs) is crucial for reducing their immunogenicity in humans. However, humanized mAbs often lose their binding affinities. Therefore, an in silico humanization method that can prevent t
Externí odkaz:
https://doaj.org/article/682be9e061ff404fb8b92628dae0d0c1
Autor:
Po-Jung Chen, Wei-Chih Su, Tsung-Kun Chang, Yen-Cheng Chen, Ching-Chun Li, Tzu-Chieh Yin, Hsiang-Lin Tsai, Cheng-Jen Ma, Ching-Wen Huang, Jaw-Yuan Wang
Publikováno v:
Asian Journal of Surgery, Vol 44, Iss 7, Pp 957-963 (2021)
Aims: This study analyzed the oncological outcomes of robotic-assisted total mesorectal excision (TME) in patients with rectal cancer after neoadjuvant concurrent chemoradiotherapy (CCRT). Methods: We enrolled 109 consecutive patients with stage II
Externí odkaz:
https://doaj.org/article/f5ea30733a8044e1a60820948ca648ad
Autor:
Chun-Ming Huang, Hsiang-Lin Tsai, Yen-Cheng Chen, Ching-Wen Huang, Ching-Chun Li, Wei-Chih Su, Tsung-Kun Chang, Yung-Sung Yeh, Po-Jung Chen, Ming-Yii Huang, Jaw-Yuan Wang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Colorectal cancer (CRC) is a global public health concern because of its high prevalence and mortality. Although radiotherapy is a key method for treating CRC, radioresistance is an obstacle to radiotherapy use. The molecular mechanisms underlying th
Externí odkaz:
https://doaj.org/article/1f532953266c4af2ab0fcda4df72ab76
Autor:
Hsiang-Lin Tsai, Po-Jung Chen, Yen-Cheng Chen, Ching-Chun Li, Tsung-Kun Chang, Wei-Chih Su, Tzu-Chieh Yin, Ching-Wen Huang, Jaw-Yuan Wang
Publikováno v:
Journal of International Medical Research, Vol 50 (2022)
Objective The UGT1A1*28 polymorphism reduces UGT1A1 enzymatic activity, which may increase the risk of severe toxicity in patients who receive standard-dose irinotecan, such as severe neutropenia and diarrhea. This real-world study assessed the optim
Externí odkaz:
https://doaj.org/article/7338ae8c5cb24fa291a554c58d0e685b